As the leading COVID-19 vaccines move closer to potential emergency use, the research and regulatory processes have been intensely scrutinized. But there’s one area that hasn’t seen as much attention so far—manufacturing facility inspections. 
[Source: www.fiercepharma.com] [ Comments ] [See why this is trending]